SON
Chr 21ADSON DNA and RNA binding protein
Also known as: BASS1, C21orf50, DBP-5, NREBP, SON3, TOKIMS
This gene encodes a protein that contains multiple simple repeats. The encoded protein binds RNA and promotes pre-mRNA splicing, particularly of transcripts with poor splice sites. The protein also recognizes a specific DNA sequence found in the human hepatitis B virus (HBV) and represses HBV core promoter activity. There is a pseudogene for this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Definitive — sufficient evidence for diagnostic panels
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Among the most LoF-intolerant genes (~top 3%)
Mild missense constraint
This gene — mechanism propensity
The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).
Literature Evidence
Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.
References
ClinVar Variant Classifications
1776 submitted variants in ClinVar
Classification Summary
Curated Variants Distribution
Classified variants from ClinVar · 5 ACMG categories
| Classification | LoF | Missense + Inframe | Non-coding | Synonymous | Total |
|---|---|---|---|---|---|
Pathogenic | 105 | 1 | 1 | 0 | 107 |
Likely Pathogenic | 42 | 3 | 2 | 0 | 47 |
VUS | 3 | 740 | 14 | 7 | 764 |
Likely Benign | 1 | 235 | 25 | 419 | 680 |
Benign | 2 | 61 | 18 | 22 | 103 |
Conflicting | — | 57 | |||
| Total | 153 | 1,040 | 60 | 448 | 1,758 |
LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly
View in ClinVar →65 pathogenic / likely-pathogenic (of 76) ClinVar copy-number / structural variants overlap SON — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →
Protein Context — Lollipop Plot
SON · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RECRUITINGHigh Definition Medicine for Solid Tumors Oncology
RECRUITINGThe Effect of Interventional Procedures on Serum CGRP and PACAP-38 Levels in Chronic Migraine
ACTIVE NOT RECRUITINGOnline Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
RECRUITINGStudy of Elranatamab for Relapsed or Refractory Myeloma in Patients Previously Exposed to Three-drug Classes
ACTIVE NOT RECRUITINGElacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer
RECRUITINGUtilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients
RECRUITINGActivity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients
ACTIVE NOT RECRUITINGRegistry Study of Pregnancy and Breast Cancer
ACTIVE NOT RECRUITINGA Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting
RECRUITINGA Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
ACTIVE NOT RECRUITINGA Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
RECRUITINGExternal Resources
Links to major genomics databases and tools